ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q2 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,785,000 | -97.8% | 20,000 | -97.4% | 0.01% | -98.0% |
| Q1 2023 | $82,678,414 | +80.7% | 771,110 | +105.8% | 0.26% | +64.1% |
| Q4 2022 | $45,763,332 | +15.4% | 374,710 | -2.5% | 0.16% | -1.3% |
| Q3 2022 | $39,672,000 | +1119.2% | 384,200 | +997.7% | 0.16% | +1028.6% |
| Q2 2022 | $3,254,000 | -78.4% | 35,000 | -68.8% | 0.01% | -76.7% |
| Q4 2021 | $15,094,000 | +2.6% | 112,200 | +21.5% | 0.06% | -7.7% |
| Q3 2021 | $14,713,000 | +31.4% | 92,309 | +8.5% | 0.06% | +30.0% |
| Q2 2021 | $11,195,000 | +148.2% | 85,100 | +143.1% | 0.05% | +138.1% |
| Q1 2021 | $4,511,000 | -35.1% | 35,000 | -16.1% | 0.02% | -38.2% |
| Q4 2020 | $6,955,000 | -14.9% | 41,700 | -42.6% | 0.03% | -48.5% |
| Q1 2020 | $8,175,000 | – | 72,600 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |